Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Rx Safety Website Will Include Drugs With Emerging Off-Label Issues

May 09 2005

• By The Pink Sheet

Related Content

CDER Drug Safety Website Model Includes Elidel; Novartis Objects

Apr 25 2005

Celebrex Should Stay On Market, FDA Panel Says, But Splits On Vioxx, Bextra

Feb 21 2005

FDA Public Information Strategy Is “Dangerous” And “Imprecise” – AEI Fellow

May 02 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window